Abstract
Inosine is an endogenous purine nucleoside, which is formed during the breakdown of adenosine. The adenosinergic system was already described as capable of modulating mood in preclinical models; we now explored the effects of inosine in two predictive models of depression: the forced swim test (FST) and tail suspension test (TST). Mice treated with inosine displayed higher anti-immobility in the FST (5 and 50 mg/kg, intraperitoneal route (i.p.)) and in the TST (1 and 10 mg/kg, i.p.) when compared to vehicle-treated groups. These antidepressant-like effects started 30 min and lasted for 2 h after intraperitoneal administration of inosine and were not accompanied by any changes in the ambulatory activity in the open-field test. Both adenosine A1 and A2A receptor antagonists prevented the antidepressant-like effect of inosine in the FST. In addition, the administration of an adenosine deaminase inhibitor (1 and 10 mg/kg, i.p.) also caused an antidepressant-like effect in the FST. These results indicate that inosine possesses an antidepressant-like effect in the FST and TST probably through the activation of adenosine A1 and A2A receptors, further reinforcing the potential of targeting the purinergic system to the management of mood disorders.
References
Andlin-Sobocki P, Jonsson B, Wittchen HU, Olesen J (2005) Cost of disorders of the brain in Europe. Eur J Neurol 12(Suppl 1):1–27
Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE (2005) Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psych 62(6):593–602
Gomes CV, Kaster MP, Tome AR, Agostinho PM, Cunha RA (2012) Adenosine receptors and brain diseases: neuroprotection and neurodegeneration. Biochim Biophys Acta 1808(5):1380–1399
Cunha RA, Ferré S, Vaugeois JM, Chen JF (2008) Potential therapeutic interest of adenosine A2A receptors in psychiatric disorders. Curr Pharmacol Des 14(15):1512–1524
Scaccianoce S, Navarra D, Sciullo AD, Angelucci L, Endröczi E (1989) Adenosine and pituitary–adrenocortical axis activity in the rat. Neuroendocrinology 50:464–468
Okada M, Nutt DJ, Murakami T, Zhu G, Kamata A, Kawata Y, Kaneko S (2001) Adenosine receptor subtypes modulate two major functional pathways for hippocampal serotonin release. J Neurosci 21:628–640
Barankiewicz J, Cohen A (1985) Purine nucleotide metabolism in resident and activated rat macrophages in vitro. Eur J Immunol 15(6):627–631
Fredholm BB, Sollevi A (1981) The release of adenosine and inosine from canine subcutaneous adipose tissue by nerve stimulation and noradrenaline. J Physiol 313:351–367
Benowitz LI, Goldberg DE, Irwin N (2002) Inosine stimulates axon growth in vitro and in the adult CNS. Prog Brain Res 137:389–399
Haskó G, Sitkovsky MV, Szabo C (2004) Immunomodulatory and neuroprotective effects of inosine. Trends Pharmacological Sci 25(3):152–157
Kovacs Z, Dobolyi A, Juhasz G, Kekesi KA (2009) Nucleoside map of the human central nervous system. Neurochem Res 35(3):452–464
Marchand WR, Lee JN, Suchy Y, Johnson S, Thatcher J, Gale P (2012) Aberrant functional connectivity of cortico-basal ganglia circuits in major depression. Neurosci Lett 514(1):86–90
Liu F, You SW, Yao LP, Liu HL, Jiao XY, Shi M, Zhao QB, Ju G (2006) Secondary degeneration reduced by inosine after spinal cord injury in rats. Spinal Cord 44(7):421–426
Hasko G, Kuhel DG, Nemeth ZH, Mabley JG, Stachlewitz RF, Virag L, Lohinai Z, Southan GJ, Salzman AL, Szabo C (2000) Inosine inhibits inflammatory cytokine production by a posttranscriptional mechanism and protects against endotoxin-induced shock. J Immunol 164(2):1013–1019
Liaudet L, Mabley JG, Soriano FG, Pacher P, Marton A, Hasko G, Szabo C (2001) Inosine reduces systemic inflammation and improves survival in septic shock induced by cecal ligation and puncture. Am J Respir Crit Medicine 164(7):1213–1220
Nascimento FP, Figueredo SM, Marcon R, Martins DF, Macedo SJ Jr, Lima DA, Almeida RC, Ostroski RM, Rodrigues AL, Santos AR (2010) Inosine reduces pain-related behavior in mice: involvement of adenosine A1 and A2A receptor subtypes and protein kinase C pathways. J Pharmacol Exp Therapeut 334(2):590–598
Macedo-Júnior SJ, Nascimento FP, Luiz-Cerutti M, Santos AR (2013) Role of pertussis toxin-sensitive G-protein, K+ channels, and voltage-gated Ca2+ channels in the antinociceptive effect of inosine. Purinergic Signal 9(1):51–58
Irwin N, Li YM, O'Toole JE, Benowitz LI (2006) Mst3b, a purine-sensitive Ste20-like protein kinase, regulates axon outgrowth. Proc Natl Acad Sci U S A 103(48):18320–18325
Chen P, Goldberg DE, Kolb B, Lanser M, Benowitz LI (2002) Inosine induces axonal rewiring and improves behavioral outcome after stroke. Proc Natl Acad Sci USA 99(13):9031–9036
Giannecchini M, Matteucci M, Pesi R, Sgarrella F, Tozzi MG, Camici M (2005) Uptake and utilization of nucleosides for energy repletion. Int J Biochem Cell Biol 37(4):797–808
Kaster MP, Rosa AO, Rosso MM, Goulart EC, Santos AR, Rodrigues AL (2004) Adenosine administration produces an antidepressant-like effect in mice: evidence for the involvement of A1 and A2A receptors. Neurosci Lett 355(1–2):21–24
Martins DF, Mazzardo-Martins L, Soldi F, Stramosk J, Piovezan AP, Santos AR (2013) High-intensity swimming exercise reduces neuropathic pain in an animal model of complex regional pain syndrome type I: evidence for a role of the adenosinergic system. Neuroscience 3(234):69–76
Porsolt RD, Bertin A, Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229(2):327–336
Kaster MP, Budni J, Binfare RW, Santos AR, Rodrigues AL (2007) The inhibition of different types of potassium channels underlies the antidepressant-like effect of adenosine in the mouse forced swimming test. Prog Neuropsychopharmacol Biol Psychiatry 31(3):690–696
Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85(3):367–370
Posser T, Kaster MP, Barauna SC, Rocha JB, Rodrigues AL, Leal RB (2009) Antidepressant-like effect of the organoselenium compound ebselen in mice: evidence for the involvement of the monoaminergic system. Eur J Pharmacol 602(1):85–91
Bai F, Li X, Clay M, Lindstrom T, Skolnick P (2001) Intra- and interstrain differences in models of “behavioral despair”. Pharmacol Biochem Behav 70:187–192
Bettio LE, Cunha MP, Budni J, Pazini FL, Oliveira A, Colla AR, Rodrigues AL (2012) Guanosine produces an antidepressant-like effect through the modulation of NMDA receptors, nitric oxide-cGMP and PI3K/mTOR pathways. Behav Brain Res 234(2):137–148
Eckeli AL, Dach F, Rodrigues AL (2000) Acute treatments with GMP produce antidepressant-like effects in mice. Neuroreport 11(9):1839–1843
Deng YH, Kuang SJ, Hei MY, Tian L (2006) Effects of inosine on neuronal apoptosis and the expression of cytochrome C mRNA following hypoxic–ischemic brain damage in neonatal rats. Chinese J Contemp Ped 8(4):266–271
Wu MM, You SW, Hou B, Jiao XY, Li YY, Ju G (2003) Effects of inosine on axonal regeneration of axotomized retinal ganglion cells in adult rats. Neurosci Lett 341(1):84–86
Starling RD, Trappe TA, Short KR, Sheffield-Moore M, Jozsi AC, Fink WJ, Costill DL (1996) Effect of inosine supplementation on aerobic and anaerobic cycling performance. Med Science SportsExerc 28(9):1193–1198
McNaughton L, Dalton B, Tarr J (1999) Inosine supplementation has no effect on aerobic or anaerobic cycling performance. Int J Sport Nut 9(4):333–344
Lobato KR, Binfare RW, Budni J, Rosa AO, Santos AR, Rodrigues AL (2008) Involvement of the adenosine A1 and A2A receptors in the antidepressant-like effect of zinc in the forced swimming test. Prog Neuro-Psychopharmacol Biol Psych 32(4):994–999
Gao Z, Li BS, Day YJ, Linden J (2001) A3 adenosine receptor activation triggers phosphorylation of protein kinase B and protects rat basophilic leukemia 2H3 mast cells from apoptosis. Mol Pharmacol 59(1):76–82
Szabo C, Dawson VL (1998) Role of poly(ADP-ribose) synthetase in inflammation and ischaemia-reperfusion. Trends Pharmacol Sci 19(7):287–298
Ames BN, Cathcart R, Schwiers E, Hochstein P (1981) Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis. Proc Natl Acad Sci U S A 78(11):6858–6862
Becker BF, Reinholz N, Ozcelik T, Leipert B, Gerlach E (1989) Uric acid as radical scavenger and antioxidant in the heart. Pflugers Arch 415(2):127–135
Wen S, Cheng M, Wang H, Yue J, Wang H, Li G, Zheng L, Zhong Z, Peng F (2012) Serum uric acid levels and the clinical characteristics of depression. Clinical Biochem 45(1–2):49–53
Pastor-Anglada M, Casado FJ, Valdes R, Mata J, Garcia-Manteiga J, Molina M (2001) Complex regulation of nucleoside transporter expression in epithelial and immune system cells. Mol Mem Biol 18(1):81–85
Acknowledgments
This study was supported by CNPq, CAPES, IBN-Net, Brazil and NENASC project (PRONEX program CNPq/FAPESC).
Conflict of interest
None
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kaster, M.P., Budni, J., Gazal, M. et al. The antidepressant-like effect of inosine in the FST is associated with both adenosine A1 and A2A receptors. Purinergic Signalling 9, 481–486 (2013). https://doi.org/10.1007/s11302-013-9361-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11302-013-9361-8